![]() |
市場調查報告書
商品編碼
2028111
輸液幫浦市場規模、佔有率和成長率;全球產業分析;按類型、應用和地區分析;以及未來預測(2026-2034 年)。Infusion Pump Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
全球輸液幫浦市場預計在2025年達到127.8億美元,2026年成長至137.2億美元,到2034年達到244.9億美元,2026年至2034年的複合年成長率為7.51%。該市場呈現強勁成長勢頭,主要受對精準給藥系統需求不斷成長以及全球慢性病患病率上升的推動。
輸液幫浦是一種先進的醫療設備,用於以可控的劑量將營養液、藥物和胰島素等液體輸送到患者體內。由於其精準性和改善治療效果的能力,這些設備廣泛應用於醫院、診所和居家醫療機構。
市場趨勢
塑造市場格局的關鍵趨勢之一是智慧型輸液幫浦和家用輸液系統的進步。製造商正日益將無線連接、即時監測以及與電子健康記錄(EHR)整合等先進技術融入其中。
自從新冠肺炎疫情爆發以來,人們對居家醫療的需求激增。患者越來越傾向於在家中接受化療、糖尿病管理和疼痛管理等長期治療,這推動了攜帶式和易於使用的輸液設備的創新。
市場促進因素
慢性病盛行率上升
慢性病患者人數的不斷增加是推動市場成長的主要因素,例如糖尿病、癌症和神經系統疾病。輸液幫浦能夠實現精準、持續的藥物輸送,對於有效控制這些疾病至關重要。
例如,胰島素幫浦在糖尿病患者中越來越受歡迎,因為它可以控制胰島素的輸注量,從而提高患者的便利性和治療效率。
攜帶式水泵需求不斷成長
攜帶式輸液幫浦便於攜帶,使患者在治療期間能夠保持行動自由。這些設備廣泛應用於醫院和居家醫療機構,尤其適用於長期治療。對經濟高效治療方案和縮短住院時間的需求,進一步加速了攜帶式輸液幫浦的普及應用。
市場限制因素
儘管市場成長強勁,但仍面臨許多挑戰,例如嚴格的監管要求和產品召回。輸液幫浦的監管核准複雜且耗時,導致產品上市延遲。
此外,近年來,產品缺陷和軟體錯誤導致產品召回,損害了製造商的信譽,減緩了市場成長。
按類型
按類型分類,市場包括容積式幫浦、注射式幫浦、胰島素幫浦、腸道餵食幫浦、彈性體幫浦、植入式幫浦和病人自控鎮痛幫浦(PCA幫浦)。其中,胰島素幫浦佔據市場主導地位,並且由於全球糖尿病患者人數不斷增加,預計將繼續保持主導地位。預計到2026年,該細分市場的佔有率將達到26.04%。
透過使用
依應用領域分類,市場可分為糖尿病、腫瘤、疼痛管理和其他領域。其中,糖尿病領域佔最大佔有率,這主要得益於全球糖尿病患者人數的不斷成長以及胰島素輸注裝置的日益普及。
最終用戶
依最終用戶分類,市場可分為醫院、門診診所、專科診所和居家醫療。醫院細分市場憑藉其龐大的患者群體和先進的醫療基礎設施,預計將佔據市場主導地位,到2026年將佔市場佔有率的54.97%。然而,居家醫療細分市場預計將呈現最高的成長率。
北美洲
預計到 2025 年,北美將以 38.26% 的市場佔有率(48.9 億美元)佔據主導地位,並預計在 2026 年達到 52.3 億美元。這一成長得益於先進的醫療保健基礎設施、智慧輸液泵的高滲透率以及有利的報銷政策。
歐洲
預計到 2025 年,歐洲市場規模將達到 35.7 億美元,到 2026 年將達到 38.2 億美元。醫療保健成本上升和慢性病負擔加重是推動該地區市場成長的主要因素。
亞太地區
亞太地區正在崛起為高成長地區,預計到 2025 年市場規模將達到 26.2 億美元,到 2026 年將成長至 28.4 億美元。醫療基礎設施的快速發展和患者意識的提高正在推動需求成長。
拉丁美洲、中東和非洲
由於醫療保健系統的改善和先進醫療設備的廣泛應用,這些地區正在經歷逐步成長。
主要企業
輸液幫浦市場的主要企業包括Medtronic、貝克頓迪金森公司、百特、Inslet公司和貝朗醫療集團。這些公司正致力於產品創新、策略聯盟和拓展業務區域,以鞏固其市場地位。
2026 年至 2034 年的複合年成長率為 7.51%。
The global infusion pump market was valued at USD 12.78 billion in 2025 and is projected to grow to USD 13.72 billion in 2026, reaching USD 24.49 billion by 2034, exhibiting a CAGR of 7.51% during 2026-2034. The market is witnessing strong growth due to the rising demand for accurate drug delivery systems and increasing prevalence of chronic diseases worldwide.
Infusion pumps are advanced medical devices used to deliver fluids such as nutrients, medications, and insulin into a patient's body in controlled amounts. These devices are widely used in hospitals, clinics, and home care settings due to their precision and ability to improve treatment outcomes.
Market Trends
One of the key trends shaping the market is the growing development of smart infusion pumps and home-based infusion systems. Manufacturers are increasingly integrating advanced technologies such as wireless connectivity, real-time monitoring, and electronic health record (EHR) integration.
The demand for home healthcare has surged significantly, especially after the COVID-19 pandemic. Patients prefer receiving long-term treatments such as chemotherapy, diabetes management, and pain therapy at home, which has boosted innovation in portable and user-friendly infusion devices.
Market Growth Factors
Rising Prevalence of Chronic Diseases
The increasing number of patients suffering from chronic diseases such as diabetes, cancer, and neurological disorders is a major factor driving market growth. Infusion pumps allow precise and continuous drug delivery, which is essential for managing such conditions effectively.
For instance, insulin pumps are gaining popularity among diabetic patients as they provide controlled insulin delivery, improving patient convenience and treatment efficiency.
Growing Demand for Ambulatory Pumps
Ambulatory infusion pumps are portable and allow patients to maintain mobility during treatment. These devices are widely used in both hospital and home settings, particularly for long-term therapies. The shift toward cost-effective treatment solutions and reduced hospital stays is further accelerating their adoption.
Restraining Factors
Despite strong growth, the market faces challenges such as stringent regulatory requirements and product recalls. Regulatory approvals for infusion pumps are complex and time-consuming, which delays product launches.
Additionally, product malfunctions and software errors have led to recalls in recent years, impacting manufacturer credibility and slowing market growth.
Market Segmentation Analysis
By Type
Based on type, the market includes volumetric pumps, syringe pumps, insulin pumps, enteral feeding pumps, elastomeric pumps, implantable pumps, and PCA pumps. Among these, the insulin pump segment dominates the market and is expected to maintain its leadership due to the rising global diabetic population. The segment is projected to account for 26.04% market share in 2026.
By Application
By application, the market is segmented into diabetes, oncology, pain management, and others. The diabetes segment holds the largest share, driven by the increasing number of diabetic patients worldwide and the growing adoption of insulin delivery devices.
By End User
Based on end users, the market includes hospitals, ambulatory care settings, specialty clinics, and home care settings. The hospitals segment dominates, accounting for 54.97% share in 2026, due to high patient inflow and availability of advanced healthcare infrastructure. However, the home care segment is expected to grow at the fastest rate.
North America
North America dominated the market with a 38.26% share in 2025, valued at USD 4.89 billion, and is projected to reach USD 5.23 billion in 2026. Growth is driven by advanced healthcare infrastructure, high adoption of smart pumps, and favorable reimbursement policies.
Europe
Europe accounted for USD 3.57 billion in 2025 and is expected to reach USD 3.82 billion in 2026. Increasing healthcare expenditure and rising chronic disease burden are supporting market growth in this region.
Asia Pacific
Asia Pacific is emerging as a high-growth region, with market size reaching USD 2.62 billion in 2025 and projected to grow to USD 2.84 billion in 2026. Rapid healthcare infrastructure development and increasing patient awareness are driving demand.
Latin America and Middle East & Africa
These regions are witnessing gradual growth due to improving healthcare systems and rising adoption of advanced medical devices.
Key Companies
Leading players in the infusion pump market include Medtronic, Becton Dickinson and Company, Baxter, Insulet Corporation, and B. Braun Melsungen AG. These companies focus on product innovation, strategic partnerships, and geographic expansion to strengthen their market position.
Conclusion
In conclusion, the infusion pump market is poised for strong growth from USD 12.78 billion in 2025 to USD 24.49 billion by 2034. The increasing prevalence of chronic diseases, advancements in smart medical technologies, and rising demand for home healthcare solutions are key factors driving the market. While regulatory challenges and product recalls may hinder growth, continuous innovation and expanding healthcare access in emerging regions will create significant opportunities. Overall, the market is expected to witness sustained expansion with a strong focus on precision, safety, and patient-centric solutions.
Growth Rate CAGR of 7.51% from 2026-2034
Segmentation By Type
By Application
By End User
By Geography